Pinnacle Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$28.5M Sell
56,870
-20
-0% -$10K 0.58% 39
2024
Q4
$30.7M Sell
56,890
-49
-0.1% -$26.4K 0.62% 31
2024
Q3
$35.2M Buy
56,939
+51
+0.1% +$31.5K 0.71% 26
2024
Q2
$31.8M Sell
56,888
-27
-0% -$15.1K 0.68% 29
2024
Q1
$33.1M Buy
56,915
+569
+1% +$331K 0.72% 26
2023
Q4
$29.9M Sell
56,346
-285
-0.5% -$151K 0.71% 24
2023
Q3
$28.7M Sell
56,631
-587
-1% -$297K 0.74% 29
2023
Q2
$29.9M Buy
57,218
+92
+0.2% +$48K 0.75% 27
2023
Q1
$32.9M Buy
57,126
+784
+1% +$452K 0.88% 23
2022
Q4
$31M Buy
56,342
+633
+1% +$349K 0.9% 25
2022
Q3
$28.3M Buy
55,709
+329
+0.6% +$167K 1.02% 23
2022
Q2
$30.1M Sell
55,380
-200
-0.4% -$109K 1.07% 19
2022
Q1
$32.8M Sell
55,580
-347
-0.6% -$205K 1.04% 19
2021
Q4
$37.3M Buy
55,927
+5,125
+10% +$3.42M 1.16% 15
2021
Q3
$29M Buy
50,802
+40,244
+381% +$23M 1.02% 19
2021
Q2
$5.33M Buy
10,558
+5,494
+108% +$2.77M 0.22% 118
2021
Q1
$2.31M Buy
5,064
+66
+1% +$30.1K 0.1% 155
2020
Q4
$2.33M Sell
4,998
-96
-2% -$44.7K 0.11% 152
2020
Q3
$2.25M Sell
5,094
-179
-3% -$79.1K 0.12% 144
2020
Q2
$1.91M Buy
5,273
+83
+2% +$30.1K 0.11% 158
2020
Q1
$1.47M Buy
5,190
+92
+2% +$26.1K 0.1% 166
2019
Q4
$1.66M Buy
5,098
+60
+1% +$19.5K 0.1% 167
2019
Q3
$1.47M Buy
5,038
+339
+7% +$98.8K 0.11% 168
2019
Q2
$1.38M Buy
4,699
+12
+0.3% +$3.52K 0.1% 171
2019
Q1
$1.28M Buy
4,687
+609
+15% +$167K 0.1% 169
2018
Q4
$912K Buy
4,078
+1,271
+45% +$284K 0.09% 181
2018
Q3
$685K Buy
2,807
+21
+0.8% +$5.13K 0.06% 212
2018
Q2
$578K Buy
2,786
+263
+10% +$54.6K 0.05% 217
2018
Q1
$521K Buy
2,523
+1,009
+67% +$208K 0.05% 213
2017
Q4
$287K Buy
+1,514
New +$287K 0.03% 264
2017
Q3
Sell
-410
Closed -$72K 431
2017
Q2
$72K Buy
+410
New +$72K 0.01% 319
2013
Q4
Sell
-200
Closed -$18K 200
2013
Q3
$18K Hold
200
0.01% 138
2013
Q2
$17K Buy
+200
New +$17K 0.01% 132